business / news / / The Sunday Times
Revenue in the first three months of the year rose to £7.63 billion.
GSK's Shingrix vaccine sales rose by 20% to £1 billion this quarter.
KEY POINTS
- GSK completed a $950 million acquisition of 35Pharma for cardiopulmonary therapies in February.
- GSK is advancing bepirovirsen filings as a potential functional cure for hepatitis B.
- GSK recently received regulatory approvals for exdensur (asthma) and Blenrep (multiple myeloma) in China.
COMPANIES
Summarized by Newsio from The Sunday Times. How we summarize →